litlas
Log inCreate account

David M. Thomas

Active 1981–2026

124
Papers
20,381
Citations
77
h-index
112
i10-index

Citations

Citations per year for David M. Thomas1948: 1 citations1978: 1 citations1982: 3 citations1984: 3 citations1985: 2 citations1986: 1 citations1987: 3 citations1988: 5 citations1989: 3 citations1990: 11 citations1991: 4 citations1992: 3 citations1993: 4 citations1994: 5 citations1995: 7 citations1996: 5 citations1997: 9 citations1998: 12 citations1999: 5 citations2000: 24 citations2001: 21 citations2002: 31 citations2003: 38 citations2004: 57 citations2005: 76 citations2006: 72 citations2007: 99 citations2008: 96 citations2009: 86 citations2010: 102 citations2011: 117 citations2012: 132 citations2013: 160 citations2014: 194 citations2015: 257 citations2016: 210 citations2017: 208 citations2018: 199 citations2019: 604 citations2020: 735 citations2021: 714 citations2022: 628 citations2023: 440 citations2024: 814 citations2025: 364 citations2026: 10 citations1949–1977: no citations, so these years are not shown1979–1981: no citations, so these years are not shown1983: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,472 citing papers, 25.3% of this breakdownChina: 1,330 citing papers, 13.6% of this breakdownUnited Kingdom: 599 citing papers, 6.1% of this breakdownItaly: 503 citing papers, 5.2% of this breakdownAustralia: 481 citing papers, 4.9% of this breakdownGermany: 423 citing papers, 4.3% of this breakdownCanada: 372 citing papers, 3.8% of this breakdownFrance: 364 citing papers, 3.7% of this breakdownJapan: 305 citing papers, 3.1% of this breakdownNetherlands: 292 citing papers, 3% of this breakdownSpain: 229 citing papers, 2.4% of this breakdownSwitzerland: 191 citing papers, 2% of this breakdown
0%25.3%Other 22.6%

Institutions

Fields

  • Medicine47.6%
  • Biochemistry, Genetics and Molecular Biology37.8%
  • Neuroscience4.8%
  • Immunology and Microbiology3.6%
  • Engineering1.3%
  • Pharmacology, Toxicology and Pharmaceutics0.8%
  • Other4.1%

Topics

  • Hippo pathway signaling and YAP/TAZ4%
  • Sarcoma Diagnosis and Treatment4%
  • Cancer Genomics and Diagnostics3.3%
  • Cancer-related Molecular Pathways2.1%
  • Bone Tumor Diagnosis and Treatments1.7%
  • Childhood Cancer Survivors' Quality of Life1.4%
  • Other83.5%

Coauthors

All papers

Open in search
  1. The Hippo pathway and human cancer

    Authors: Kieran F. Harvey, Xiaomeng Zhang, David M. Thomas - Nature reviews. Cancer 2013 cited by 1,891

  2. Translational biology of osteosarcoma

    Authors: Maya Kansara, Michele W.L. Teng, Mark J. Smyth, David M. Thomas - Nature reviews. Cancer 2014 cited by 1,316

  3. Delivering precision oncology to patients with cancer

    Authors: Joaquı́n Mateo, Lotte Steuten, Philippe Aftimos, Fabrice André, D. M. Davies, Elena Garralda, Jan Geißler, Don Husereau, Iciar Martinez-Lopez, Nicola Normanno, Jorge S. Reis‐Filho, Stephen Stefani, David M. Thomas, C. Benedikt Westphalen, Emile E. Voest - Nature Medicine 2022 cited by 356

  4. Pexidartinib versus placebo for advanced tenosynovial giant cell tumour (ENLIVEN): a randomised phase 3 trial

    Authors: William D. Tap, Hans Gelderblom, Emanuela Palmerini, Jayesh Desai, Sebastian Bauer, Jean‐Yves Blay, Thierry Alcindor, Kristen N. Ganjoo, Javier Martín‐Broto, Christopher W. Ryan, David M. Thomas, Charles Peterfy, John H. Healey, Michiel A. J. van de Sande, Heather L. Gelhorn, Dale E. Shuster, Qiang Wang, Antoine Yver, Henry H. Hsu, Paul Lin, Sandra Tong-Starksen, Silvia Stacchiotti, Andrew J. Wagner - The Lancet 2019 cited by 474

  5. Whole genome, transcriptome and methylome profiling enhances actionable target discovery in high-risk pediatric cancer

    Authors: Marie Wong, Chelsea Mayoh, Loretta M. S. Lau, Dong-Anh Khuong-Quang, Mark Pinese, Amit Kumar, Paulette Barahona, Emilie Wilkie, Patricia A. Sullivan, Rachel Bowen-James, Mustafa Syed, Iñigo Martincorena, Federico Abascal, Alexandra Sherstyuk, Noemi Fuentes-Bolanos, Jonathan Baber, Peter Priestley, M. Emmy M. Dolman, Emmy D.G. Fleuren, Marie-Emilie Gauthier, Emily Mould, Velimir Gayevskiy, Andrew J. Gifford, Dylan Grebert‐Wade, Patrick Strong, Elodie Manouvrier, Meera Warby, David M. Thomas, Judy Kirk, Kathy Tucker, Tracey O’Brien, Frank Alvaro, Geoffrey McCowage, Luciano Dalla‐Pozza, Nicholas G. Gottardo, Heather Tapp, Paul Wood, Seong Lin Khaw, Jordan R. Hansford, Andrew S. Moore, Murray D. Norris, Toby N. Trahair, Richard B. Lock, Vanessa Tyrrell, Michelle Haber, Glenn M. Marshall, David S. Ziegler, Paul G. Ekert, Mark J. Cowley - Nature Medicine 2020 cited by 404

  6. Topological barrier to Cas12a activation by circular DNA nanostructures facilitates autocatalysis and transforms DNA/RNA sensing

    Authors: Fei Deng, Yi Li, Biyao Yang, Rui Sang, Wei Deng, Maya Kansara, Frank Lin, Subotheni Thavaneswaran, David M. Thomas, Ewa M. Goldys - Nature Communications 2024 cited by 129

  7. Practical Considerations for the Use of Circulating Tumor DNA in the Treatment of Patients With Cancer

    Authors: Matthew Krebs, Umberto Malapelle, Fabrice André, Luis Paz‐Ares, Martin Schüler, David M. Thomas, Gilad W. Vainer, Takayuki Yoshino, Christian Rolfo - JAMA Oncology 2022 cited by 118

  8. Clinical genomic profiling in the management of patients with soft tissue and bone sarcoma

    Authors: Mrinal M. Gounder, Narasimhan P. Agaram, Sally E. Trabucco, Victoria Robinson, Richard Ferraro, Sherri Z. Millis, Anita Krishnan, Jessica Lee, Steven Attia, Wassim Abida, Alexander Drilon, Ping Chi, Sandra P. D’ Angelo, Mark A. Dickson, Mary Lou Keohan, Ciara M. Kelly, Mark Agulnik, Sant P. Chawla, Edwin Choy, Rashmi Chugh, Christian F. Meyer, Parvathi A. Myer, Jessica L. Moore, Ross A. Okimoto, Raphael E. Pollock, Vinod Ravi, Arun S. Singh, Neeta Somaiah, Andrew J. Wagner, John H. Healey, Garrett M. Frampton, Jeffrey M. Venstrom, Jeffrey S. Ross, Marc Ladanyi, Samuel Singer, Murray F. Brennan, Gary K. Schwartz, Alexander J. Lazar, David M. Thomas, Robert G. Maki, William D. Tap, Siraj M. Ali, Dexter X. Jin - Nature Communications 2022 cited by 193

  9. Ultra‐rare sarcomas: A consensus paper from the Connective Tissue Oncology Society community of experts on the incidence threshold and the list of entities

    Authors: Silvia Stacchiotti, Anna Maria Frezza, Jean‐Yves Blay, Elizabeth H. Baldini, Sylvie Bonvalot, Judith V.M.G. Bovée, Dario Callegaro, Paolo G. Casali, RuRu Chun-Ju Chiang, George D. Demetri, Elisabeth G. Demicco, Jayesh Desai, Mikael Eriksson, Hans Gelderblom, Suzanne George, Mrinal M. Gounder, Alessandro Gronchi, Abha A. Gupta, Rick L. Haas, Andrea Hayes‐Jardon, Peter Hohenberger, Kevin B. Jones, Robin L. Jones, Bernd Kasper, Akira Kawai, David G. Kirsch, Eugene S. Kleinerman, Axel Le Cesne, Jiwon Lim, María Dolores Chirlaque López, Roberta Maestro, Rafael Marcos‐Gragera, Javier Martín‐Broto, Tomohiro Matsuda, Olivier Mir, Shreyaskumar Patel, Chandrajit P. Raut, Albiruni R. Abdul Razak, Damon R. Reed, Piotr Rutkowski, Roberta Sanfilippo, Marta Sbaraglia, Inga‐Marie Schaefer, D. Strauß, Kirsten Sundby Hall, William D. Tap, David M. Thomas, Winette T.A. van der Graaf, Winan J. van Houdt, Otto Visser, Margaret von Mehren, Andrew J. Wagner, Breelyn A. Wilky, Young‐Joo Won, Christopher D.�M. Fletcher, Angelo Paolo Dei Tos, Annalisa Trama - Cancer 2021 cited by 227

  10. Frequency of Pathogenic Germline Variants in Cancer-Susceptibility Genes in Patients With Osteosarcoma

    Authors: Lisa Mirabello, Bin Zhu, Roelof Koster, Eric Karlins, Michael Dean, Meredith Yeager, Matthew Gianferante, Logan G. Spector, Lindsay M. Morton, Danielle M. Karyadi, Leslie L. Robison, Gregory T. Armstrong, Smita Bhatia, Lei Song, Nathan Pankratz, Maísa Pinheiro, Julie M. Gastier‐Foster, Richard Görlick, Sílvia Regina Caminada de Toledo, Antônio Sérgio Petrilli, Ana Patiño‐García, Fernando Lecanda, Miriam Gutiérrez-Jimeno, Massimo Serra, Claudia Maria Hattinger, Piero Picci, Katia Scotlandi, Adrienne M. Flanagan, Roberto Tirabosco, Maria Fernanda Amary, Nilgün Kurucu, İlhan İnci, Mandy L. Ballinger, David M. Thomas, Donald A. Barkauskas, Gerardo Mejia-Baltodano, Patricia Valverde, Belynda Hicks, Bin Zhu, Mingyi Wang, Amy Hutchinson, Margaret A. Tucker, Joshua N. Sampson, Maria Teresa Landi, Neal D. Freedman, Susan M. Gapstur, Brian S. Carter, Robert N. Hoover, Stephen J. Chanock, Sharon A. Savage - JAMA Oncology 2020 cited by 252

  11. Diagnosis of fusion genes using targeted RNA sequencing

    Authors: Erin E. Heyer, Ira W. Deveson, Danson Wooi, Christina Selinger, Ruth J. Lyons, Vanessa M. Hayes, Sandra O’Toole, Mandy L. Ballinger, Devinder Gill, David M. Thomas, Tim R. Mercer, James Blackburn - Nature Communications 2019 cited by 231

  12. Tumor-associated macrophages and macrophage-related immune checkpoint expression in sarcomas

    Authors: Amanda R. Dancsok, Dongxia Gao, Anna F. Lee, Sonja E. Steigen, Jean‐Yves Blay, David M. Thomas, Robert G. Maki, Torsten O. Nielsen, Elizabeth G. Demicco - OncoImmunology 2020 cited by 178

  13. Australian Genomics: Outcomes of a 5-year national program to accelerate the integration of genomics in healthcare

    Authors: Zornitza Stark, Tiffany Boughtwood, Matilda Haas, Jeffrey Braithwaite, Clara Gaff, Ilias Goranitis, Amanda B. Spurdle, David P. Hansen, Oliver Hofmann, Nigel G. Laing, Sylvia A. Metcalfe, Ainsley J. Newson, Hamish S. Scott, Natalie Thorne, Robyn L. Ward, Marcel E. Dinger, Stephanie Best, Janet C. Long, Sean M. Grimmond, John V. Pearson, Nicola Waddell, Christopher Barnett, Matthew Cook, Michael Field, David Fielding, Stephen B. Fox, Jozef Gécz, Adam Jaffé, Richard J. Leventer, Paul J. Lockhart, Sebastian Lunke, Andrew Mallett, Julie McGaughran, Linda Mileshkin, Kátia Nones, Tony Roscioli, Ingrid E. Scheffer, Christopher Semsarian, Cas Simons, David M. Thomas, David R. Thorburn, Richard W. Tothill, Deborah White, Sally L. Dunwoodie, Peter T. Simpson, Peta Phillips, Marie‐Jo Brion, Keri Finlay, Michael C. Quinn, Tessa Mattiske, Emma Tudini, Kirsten Boggs, Séan Murray, Kathy Wells, John Cannings, Andrew Sinclair, John Christodoulou, Kathryn N. North - The American Journal of Human Genetics 2023 cited by 72

  14. The distinctive biology of cancer in adolescents and young adults

    Authors: Archie Bleyer, Ronald D. Barr, Brandon Hayes‐Lattin, David M. Thomas, Chad A. Ellis, Barry Anderson - Nature reviews. Cancer 2008 cited by 663

  15. Precision medicine: affording the successes of science

    Authors: Christine Y. Lu, Vera Terry, David M. Thomas - npj Precision Oncology 2023 cited by 64

  16. IFN-γ is required for cytotoxic T cell-dependent cancer genome immunoediting

    Authors: Kazuyoshi Takeda, M. NAKAYAMA, Yoshihiro Hayakawa, Yuko Kojima, Hiroaki Ikeda, Naoko Imai, Kouetsu Ogasawara, Ko Okumura, David M. Thomas, Mark J. Smyth - Nature Communications 2017 cited by 146

  17. Diagnosis and management of tropomyosin receptor kinase (TRK) fusion sarcomas: expert recommendations from the World Sarcoma Network

    Authors: George D. Demetri, Cristina R. Antonescu, Bodil Bjerkehagen, Judith V.M.G. Bovée, Kjetil Boye, Matías Chacón, Angelo Paolo Dei Tos, Jayesh Desai, Jonathan A. Fletcher, Hans Gelderblom, Suzanne George, Alessandro Gronchi, Rick L. Haas, Nadia Hindi, Peter Hohenberger, Heikki Joensuu, Robin L. Jones, Ian Judson, Y-K Kang, Akira Kawai, Alexander J. Lazar, Axel Le Cesne, Roberta Maestro, Robert G. Maki, Javier Martín‐Broto, Shreyaskumar Patel, Frédérique Penault‐Llorca, Chandrajit P. Raut, Piotr Rutkowski, Akmal Safwat, Marta Sbaraglia, Inga‐Marie Schaefer, Lin Shen, César Serrano, P. Schöffski, Silvia Stacchiotti, Kirsten Sundby Hall, William D. Tap, David M. Thomas, Jonathan C. Trent, Claudia Valverde, Winette T.A. van der Graaf, M. von Mehren, Andrew J. Wagner, E. Wardelmann, Yoichi Naito, John Zalcberg, Jean‐Yves Blay - Annals of Oncology 2020 cited by 145

  18. Li-Fraumeni syndrome: cancer risk assessment and clinical management

    Authors: Kate A. McBride, Mandy L. Ballinger, Emma Killick, Judy Kirk, Martin H.N. Tattersall, Rosalind A. Eeles, David M. Thomas, Gillian Mitchell - Nature Reviews Clinical Oncology 2014 cited by 276

  19. Baseline Surveillance in Li-Fraumeni Syndrome Using Whole-Body Magnetic Resonance Imaging

    Authors: Mandy L. Ballinger, Ana F. Best, Phuong L. Mai, Payal P. Khincha, Jennifer T. Loud, June A. Peters, Maria Isabel Achatz, Rubens Chojniak, Alexandre André Balieiro Anastácio da Costa, Karina Miranda Santiago, Judy E. Garber, Allison F. O’Neill, Rosalind A. Eeles, D. Gareth Evans, Eveline M. A. Bleiker, Gabe S. Sonke, Mariëlle Ruijs, Claudette E. Loo, Joshua D. Schiffman, Anne Naumer, Wendy Kohlmann, Louise C. Strong, Jasmina Bojadzieva, David Malkin, Surya P. Rednam, Elena M. Stoffel, Erika Koeppe, Jeffrey N. Weitzel, Thomas P. Slavin, Bita Nehoray, Mark E. Robson, Michael F. Walsh, Lorenzo Manelli, Anita Villani, David M. Thomas, Sharon A. Savage - JAMA Oncology 2017 cited by 194

  20. FGFR Genetic Alterations Predict for Sensitivity to NVP-BGJ398, a Selective Pan-FGFR Inhibitor

    Authors: Vito Guagnano, Audrey Kauffmann, Simon Wöhrle, Christelle Stamm, Moriko Ito, Louise Barys, Astrid Pornon, Yao Yao, Fang Li, Yun Zhang, Zhi Chen, Christopher J. Wilson, Vincent Bordas, Mickaël Le Douget, L. Alex Gaither, Jason Borawski, John E. Monahan, K. Venkatesan, Thomas Brümmendorf, David M. Thomas, Carlos Garcı́a-Echeverrı́a, Francesco Hofmann, William R. Sellers, Diana Graus-Porta - Cancer Discovery 2012 cited by 364

  21. The Architecture and Evolution of Cancer Neochromosomes

    Authors: Dale W. Garsed, Owen J. Marshall, Vincent Corbin, Arthur Hsu, Leon Di Stefano, Jan Schröder, Jason Li, Zhiping Feng, Bo Won Kim, Mark Kowarsky, Ben Lansdell, Ross Brookwell, Ola Myklebost, Leonardo A. Meza‐Zepeda, Andrew J. Holloway, Florence Pédeutour, K.H. Andy Choo, Michael A. Damore, Andrew J. Deans, Anthony T. Papenfuss, David M. Thomas - Cancer Cell 2014 cited by 200

  22. Benefits and Adverse Events in Younger Versus Older Patients Receiving Neoadjuvant Chemotherapy for Osteosarcoma: Findings From a Meta-Analysis

    Authors: Marnie Collins, Miriam Wilhelm, Rachel Conyers, Alan Herschtal, Jeremy Whelan, Stefan Bielack, Leo Kager, Thomas Kühne, Matthew R. Sydes, Hans Gelderblom, Stefano Ferrari, Piero Picci, Sigbjørn Smeland, Mikael Eriksson, Antônio Sérgio Petrilli, Archie Bleyer, David M. Thomas - Journal of Clinical Oncology 2013 cited by 186

  23. MTOR signaling orchestrates stress-induced mutagenesis, facilitating adaptive evolution in cancer

    Authors: Arcadi Cipponi, David L. Goode, Justin Bedő, Mark J. McCabe, Marina Pajic, David R. Croucher, Álvaro González-Rajal, Simon Junankar, Darren N. Saunders, Pavel Lobachevsky, Anthony T. Papenfuss, Danielle Nessem, Max Nobis, Sean Warren, Paul Timpson, Mark J. Cowley, Ana Cristina Vargas, Min Qiu, Daniele Generali, Shivakumar Keerthikumar, Uyen Nguyen, Niall M. Corcoran, Georgina V. Long, Jean‐Yves Blay, David M. Thomas - Science 2020 cited by 107

  24. Limited clinical activity of palbociclib and ribociclib monotherapy in advanced cancers with cyclinD‐CDK4/6 pathway alterations in the DutchDRUPand AustralianMoSTtrials

    Authors: Laurien J. Zeverijn, Eleonora J. Looze, Subotheni Thavaneswaran, Jade M. van Berge Henegouwen, R. J. Simes, Louisa R. Hoes, Katrin Marie Sjoquist, Hanneke van der Wijngaart, Lucille Sebastian, Birgit S. Geurts, Chee Khoon Lee, G.F. de Wit, David Espinoza, Paul Roepman, Frank Lin, Anne M.L. Jansen, Wendy W.J. de Leng, Vincent van der Noort, Lindsay V.M. Leek, Filip De Vos, Carla M.L. van Herpen, Hans Gelderblom, Henk M.W. Verheul, David M. Thomas, Emile E. Voest - International Journal of Cancer 2023 cited by 23